-
-
-
-
-
-
-
Canaccord Reiterates Buy Rating on Castle Biosciences (CSTL)
-
-
-
-
-
-
-
Castle Biosciences (CSTL) PT Raised to $38 at BTIG
-
-
-
-
-
-
-
Castle Biosciences Inc. (CSTL) Tops Q2 EPS by 66c
-
-
-
-
-
-
-
Castle Biosciences (CSTL) PT Lowered to $32 at BTIG
-
-
-
-
-
-
-
Castle Biosciences (CSTL) Highlights Progress for its Pipeline Atopic Dermatitis Gene Expression Profile Test
-
-
-
-
-
-
-
Castle Biosciences (CSTL) PT Raised to $42 at Canaccord Genuity
-
-
-
-
-
416,850 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

